Not Tagged
Not Tagged
['bcsm', 'i-spy2', 'i-spy', 'jacob']
611 jacob: prospective pros from i-spy2 trial. fatigue &amp; physical/cognitive fxn all worsened during tx &amp; were persistently worse after treatment (long term qol implications of novel #bcsm therapies!). however, anxiety improved during &amp; after tx. #asco23 
Lymphoma doc & patient-reported outcomes researcher in #lymsm and #mmsm @CUHematology. Founder of https://t.co/kN6qeGFEox, @inTrainingDoc & @inHouseMag. 🏳️‍🌈